Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2022 | Kallyope | $240.0M Series D | The Column Group | Andreessen Horowitz, Contrarian Ventures, INKEF Capital, Lux Capital, Mosaic Ventures, PentaLab, Union Square Ventures, Wind Ventures, Bill Gates, Alexandria Venture Investments, Casdin Capital, DNS Capital, Euclidean Capital, Illumina Ventures, Parkwood, Polaris Partners, StepStone Group, Tao Capital, Two Sigma Ventures |
| Apr 1, 2021 | Janux Therapeutics | $130.0M Series B | RA Capital Management | Avalon Ventures, Domain Associates, OrbiMed, Osage University Partners, Pivotal bioVenture Partners, RA Capital, RiverVest, Jonathan Root, Heather Preston, Bregua Corporation, BVF Partners, EcoR1 Capital, Janus Henderson Investors, Logos Capital, Samsara BioCapital, Surveyor Capital |
| Mar 1, 2019 | Surrozen | $50.0M Series B | — | Canaan Partners, The Column Group, Horizons Ventures, NS Investment |